| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV.IY.04.040186.000305 |
| P698 | PubMed publication ID | 2939855 |
| P2093 | author name string | Andersson J | |
| Melchers F | |||
| P304 | page(s) | 13-36 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | Annual Review of Immunology | Q567362 |
| P1476 | title | Factors controlling the B-cell cycle | |
| P478 | volume | 4 |
| Q28115527 | A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas |
| Q68040722 | An in vitro model for cell-cell interactions |
| Q30453916 | Analysis of lipopolysaccharide-response genes in B-lineage cells demonstrates that they can have differentiation stage-restricted expression and contain SH2 domains. |
| Q36350476 | Autoantibodies in chronic graft versus host result from cognate T-B interactions |
| Q39508590 | B-lymphocyte signal transduction in response to anti-immunoglobulin and bacterial lipopolysaccharide. |
| Q39657692 | Biochemistry of the cell cycle |
| Q56964727 | CDw40 and BLCa-specific monoclonal antibodies detect two distinct molecules which transmit progression signals to human B lymphocytes |
| Q38623542 | Control of humoral immune responses by arachidonic acid metabolites |
| Q41016632 | Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density |
| Q42805800 | Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors |
| Q38687601 | How can we cure leukaemia? |
| Q52114558 | Idiotypic networks incorporating T-B cell co-operation. The conditions for percolation. |
| Q39612163 | Immunoglobulin structural diversities and idiotypic expression |
| Q42144178 | Immunoglobulin subunits of murine B lymphocytes: structure and associations with other membrane proteins |
| Q41080984 | Immunosuppressive effect induced by Actinobacillus actinomycetemcomitans: effect on immunoglobulin production and lymphokine synthesis |
| Q68448471 | Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine an inhibitor of polyamine synthesis: I. Effects on mitogen-induced immunoglobulin production in human cultured lymphocytes |
| Q68834353 | Impaired immunoglobulin G production in minimal change nephrotic syndrome in adults |
| Q44277566 | In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone |
| Q43900102 | Induction of IgM secretion by chronic B-lymphocytic leukaemia cells in serum-free medium: effects of interferon-alpha, -gamma and phorbol ester |
| Q36835579 | Interleukin 5 (IL-5) and Its Receptor |
| Q37397525 | Interleukin 5 in the link between the innate and acquired immune response |
| Q40602176 | Interleukin-5 and its receptor system: implications in the immune system and inflammation. |
| Q70162822 | Interleukins 1, 4 and 6 induce the colony formation of human bone marrow B lineage cells |
| Q47911842 | Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies |
| Q41715687 | Low IgG2 and polysaccharide response in a T cell receptor expression defect |
| Q39480803 | Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus |
| Q34326568 | Nerve growth factor induces growth and differentiation of human B lymphocytes |
| Q39695609 | Neuropeptide regulation of mucosal immunity |
| Q35831183 | Peripheral T-cell lymphomas. Immunophenotype, lymphokine production, and immunologic functional characteristics of the lymph-node malignant T cells. |
| Q45162282 | Phenotype, activation and lymphokine secretion by gamma/delta T lymphocytes from schistosomiasis and carcinoma of the urinary bladder |
| Q37384846 | Polarized expression of cytokines in cell conjugates of helper T cells and splenic B cells |
| Q38194250 | Polyclonal activation and experimental nephropathies |
| Q34635996 | Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II. |
| Q36355310 | Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication |
| Q44650166 | Regulation of Isotype Immunoglobulin Production by Adjuvants in Vivo |
| Q52099697 | Relative frequencies of secondary B cells activated by cognatevs. other mechanisms |
| Q69379035 | Severe T lymphocyte immunodeficiency associated with hypogammaglobulinemia: defective lymphokine secretion but enhanced autologous mixed lymphocyte reaction |
| Q46270682 | Starting at the end. |
| Q38655812 | Structure, function, and genetics of human B cell-associated surface molecules |
| Q39595631 | Surface antigens associated with human B cell activation |
| Q39640081 | T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties |
| Q29619721 | T-cell antigen receptor genes and T-cell recognition |
| Q39679277 | T-independent activation of single B cells: an orderly analysis of overlapping stages in the activation pathway |
| Q41341172 | The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells |
| Q39483737 | Theoretical and practical aspects of B-cell activation: murine and human systems |
| Q36785714 | Two-step stimulation of B lymphocytes to enter DNA synthesis: synergy between anti-immunoglobulin antibody and cytochalasin on expression of c-myc and a G1-specific gene |
| Q44374965 | Unreasonable implications of reasonable idiotypic network assumptions |
Search more.